Journal of Diabetes Research
Volume 2019 (2019), Article ID 4134937, 8 pages
https://doi.org/10.1155/2019/4134937

Review Article

The Burden of Undiagnosed Diabetes Mellitus in Adult African Population: A Systematic Review and Meta-Analysis

Daniel Asmelash¹ and Yemane Asmelash²

¹Department of Clinical Chemistry, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
²Department of Statistics, College of Computational and Natural Science, Aksum University, Aksum, Ethiopia

Correspondence should be addressed to Daniel Asmelash; daniel.asmelash111@gmail.com

Received 28 September 2018; Revised 23 March 2019; Accepted 28 March 2019; Published 28 April 2019

Academic Editor: Daisuke Koya

Copyright © 2019 Daniel Asmelash and Yemane Asmelash. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. The prevalence of diabetes is rapidly increasing in Africa. Type two diabetes may remain undetected for many years, leading to severe complications and healthcare costs. This underlines the importance of understanding the magnitude of undiagnosed diabetes in different populations of Africa. This study is intended to summarize and pool the results of community-based studies to provide a continental level estimate of the undiagnosed diabetes mellitus. Methods. We searched MEDLINE/PubMed, HINARI, Cochrane Library, and Google Scholar for community-based studies on diabetes mellitus in Africa. Descriptive information for the original studies was presented in a table, and the quantitative results were presented in forest plots. The Cochran’s test and test statistic were used to test heterogeneity across studies. The pooled prevalence of undiagnosed diabetes and subgroup analyses within urban and rural population and diagnostic methods were computed by a random effects model from 2011 to 2017. Results. One hundred fifty-seven articles were identified through electronic searching using keywords. Of these, seventeen studies, with a total population of 20,350, met the inclusion criteria. A random effects meta-analysis showed that the pooled prevalence of undiagnosed diabetes mellitus in African population was 5.37% (95% CI: 4.57, 6.81). The pooled prevalence from subgroup analyses indicated that undiagnosed diabetes mellitus in the urban population (8.68%, 95% CI: 5.33, 12.03) is twice higher than that in the rural population (3.93%, 95% CI: 2.91, 4.95). The prevalence of UDM by OGTT (8.84%, 95% CI: 1.95, 15.73) was higher than that by the FPG diagnostic method (4.54%, 95% CI: 3.59, 5.49). Conclusion. This study found high proportions of undiagnosed diabetes mellitus in different communities of the African countries. Policy makers must consider diagnostic strategies to improve screening for the undiagnosed diabetes mellitus cases for effective care, which can bring about a substantial reduction in diabetes-related complications and mortality. This review is registered with PROSPERO registration number CRD42018092637.

1. Introduction

Diabetes mellitus (DM) with other noncommunicable diseases is responsible for an increasing burden of diseases in developing countries. In Sub-Saharan Africa, noncommunicable diseases are predicted to exceed infectious diseases by the year 2030 [1, 2].

The International Diabetes Federation estimates that there are approximately 425 million adults (20-79 years) who were living with diabetes in 2017 with a projected increase of 629 million by 2045 [3]. Globally, 45.8% of all diabetes cases, or 174.8 million people, are estimated to have undiagnosed diabetes mellitus (UDM) in 2013 [4]. In 2013, diabetes was responsible for 74.9 thousand deaths, which is the seventh leading cause of death, and 1.85 million years living with disability, which is the eighth leading cause of disability [5].

In addition to a health burden, diabetes-related health expenditures incur heavy cost on individuals, health systems, and governments. The global health expenditure on diabetes is expected to total at least 376 billion USD in 2010 and 490 billion USD in 2030. Globally, 12% of the health expenditures are anticipated to be spent on diabetes in 2010. UDM causes an additional cost of 2864 USD which was spent per person per year, and this is due to higher diabetic complication among UDM cases [6].

There are factors for DM cases that remain undiagnosed for many years, which include poor health systems, lack of awareness in the general population and health professionals, and slow onset of the symptoms or progression of type 2 diabetes [4, 7]. UDM is characterized by uncontrolled elevated blood glucose, which leads to the development of micro- and macrovascular complications, including neuropathy, nephropathy, retinopathy, coronary artery disease, stroke, and peripheral vascular disease [8]. The finding from a study done in the USA showed that up to 41.7% of adults with newly diagnosed diabetes have developed chronic kidney disease [9].

Studies around the world reported a different level in the prevalence of UDM. The prevalence of UDM in studies done on the general population was 7% in India [10], 5.9% in Qatar [11], 4.1% in the USA (28.6% of all diabetes cases) [5], 5.1% in Iran (56% of all diabetes cases) [12], 2.9% in Russia (53% of all diabetes cases) [13], and 4.1% in China [14].

In Africa, the prevalence of UDM is not consistent in the different countries as a result of a difference in social, economic, and genetic disparities. The prevalence of UDM in North Africa ranged from 18% to 75% of all diabetes cases [15]. Moreover, the prevalence of UDM in different regions of Africa were shown as follows: 9% in Tanzania [16], 7.2%, 11.5%, 5%, 2.3%, 3.8%, and 2.13% in Ethiopia [1, 17–21], and 2.6% and 5.97% in North Sudan [22] (East African studies); 3.19% in Guinea [23], 6.3% in Cameroon [24], 4.77% in Mauritania [25], 4.64% in Senegal [26], and 7% and 4.6% in Nigeria [27, 28]) (West African studies); 18.1% in South Africa [29]; and 4.2% in Egypt (North Africa) [30].

The early detection and intervention of DM have an enormous benefit, which is only possible when there is evidence showing the magnitude and risks of diabetes [1]. While the existence of UDM has long been recognized, wide-reaching awareness among the general public, physicians, and policy makers is lacking and there are limited reliable and comparable data available. Given the fact that UDM has been rising in African countries, this meta-analysis is designed to summarize the most currently available evidence among adult African populations.

2. Methods

2.1. Literature Search Strategy/Data Source

A systematic meta-analysis was done using published articles on the prevalence of UDM in Africa. The studies were found through Internet searches using the PubMed, Google Scholar, HINARI, and Cochrane Library databases. The exploration was done using the following keywords individually or in combination: Undiagnosed or (Newly diagnosed)) AND (Diabetes mellitus or (DM)) AND (Prevalence or (Burden)) AND (Africa). Only articles written in English were considered. The searching of articles was carried out from December 2017 to February 2018, and research articles done in the last 10 years from 2008 to 2018 were included in the meta-analysis to determine the magnitude of UDM among adult populations in Africa.

2.2. Study Selection

Studies were selected for the meta-analysis if they were community-based studies done in Africa and stated the prevalence of UDM. After finding all the articles from Internet searches, all papers were then assessed for eligibility by two independent researchers based on the inclusion criteria. Difference between the two researchers was resolved through discussion and consensus. Lastly, studies that met all of the following criteria were included in the meta-analysis: cross-sectional studies that were conducted in the age group of 15 years and above and done in Africa, studies that used fasting blood glucose (FPG), hemoglobin A1c (HbA1c), and oral glucose tolerance test (OGTT) for classification of diabetes mellitus, studies that reported the prevalence of UDM, and studies that used original data and a random sampling technique.

2.3. Data Extraction Tool

Data extraction was done using a standardized and pretested format. Data extraction included the following: title, first author, publication year, year of the study, design of the study, population-based study, settings (urban, rural), sample size, data collection procedure, age group of study participants, study places, sampling methods, method of diagnosis used for UDM, and crude prevalence of UDM.

2.4. Operational Definition of UDM

Participants do not report a previous diabetes diagnosis, but they found to have diabetes upon tests of their blood glucose and were classified as having UDM or newly diagnosed diabetes. UDM was defined according to the 1999 WHO diagnostic criteria based on fasting blood glucose (FPG) of ≥126 mg/dl or ≥7.0 mmol/l, , and OGTT value of ≥11.1 mmol/l 2 h postoral glucose load [31].

2.5. Quality Assessment Systems

Evaluation of internal validity of study results, proper sampling methods, clear data collection methods and procedures, reported quality assurance methods (training of data collectors, pretesting, and supervision), and representative sample size were considered study quality indicators.

All quality assessments were entered into standardized data extraction forms. Two authors separately assessed the quality of the studies included using the NIH Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. Studies that scored a moderate-to-high quality were involved in the analysis. Disagreements of their assessment results were resolved by taking the mean score of the two researchers.

2.6. Statistical Data Analysis

The data entry and analysis were done using Excel 2016 and Stata version 11.0 (Stata Corporation, College Station, Texas) software, respectively. The original articles were described using a forest plot and table. The random effects model was used to compute the pooled prevalence and subgroup analysis of UDM. The random effects model was applied to explain any heterogeneity inherent in the meta-analysis. The estimated pooled prevalence rate with its 95% confidence interval (CI) was introduced. Subgroup analyses were performed for residency (rural and urban) and diagnostic methods (OGTT, HbA1c, and FPG).

2.7. Heterogeneity and Publication Bias

Statistical heterogeneity was evaluated by Cochran’s test, which shows the amount of heterogeneity between studies, and statistic. The statistic was used to estimate the variation (heterogeneity) in the prevalence of UDM among the different African countries, their residence place, and diagnostic methods. represents the percentage of the total variation in estimated effects across studies due to heterogeneity rather than chance differences. The Begg rank correlation and Egger weighted regression method were used to statistically assess publication bias. is considered suggestive of statistically significant publication bias.

3. Results

We identified one hundred fifty-seven articles by the electronic search in MEDLINE/PubMed, Google Scholar, HINARI, and Cochrane Library. Of which, 140 were excluded by the exclusion criteria. Finally, seventeen studies were found to be eligible and included in the meta-analysis (Figure 1).

Figure 1: Flow chart for the selection of studies on UDM in Africa.

3.1. Study Characteristics

All of the 17 cross-sectional studies included in the meta-analysis were population-based studies. The study populations varied from 382 studies done in Tanzania [16] to 4371 in Ethiopia [21], and these studies were conducted between the years 2011 and 2017. These studies represented the four regions of the continent: West [23–28], East [1, 16–22, 32], Southern [29], and North [30] Africa. The prevalence of UDM varied extensively between studies, ranging from a minimum of 2.3% [20] to a maximum of 18.1% [29], in studies done in South Africa (Table 1). The high prevalence of diabetes (18.1%) in the colored population of South Africa may be due to significant obesity and the economic transition of a community.

Table 1: The characteristics of studies included in the meta-analysis of the prevalence of UDM in African population ().

Article ID
Residence
Country
Region in Africa
Dx lab method
Study design
Sample size ()
Prevalence of UDM (%)

Sabir et al. [27]
Rural
Nigeria
West
OGTT
Cross-sectional
389
4.6

Erasmus et al. [29]
Urban
South Africa
South
OGTT
Cross-sectional
642
18.1

Echouffo-Tcheugui et al. [24]
Urban
Cameroon
Central
FPG
Cross-sectional
1591
6.3

Seck et al. [26]
Rural and urban
Senegal
West
FPG
Cross-sectional
1026
4.64

Megerssa et al. [18]
Urban
Ethiopia
East
FPG
Cross-sectional
422
5

Meiloud et al. [25]
Rural and urban
Mauritania
Western
FPG
Cross-sectional
1278
4.77

Seifu et al. [21]
Rural
Ethiopia
East
FPG
Cross-sectional
4371
3.8

Abebe et al. [17]
Rural and urban
Ethiopia
East
FPG
Cross-sectional
2141
2.47

Enang et al. [28]
Rural
Nigeria
West
FPG
Cross-sectional
1134
6.5

Noor et al. [22]
Rural
Sudan
East
FPG
Cross-sectional
1111
2.6

Wondemagegn et al. [19]
Rural and urban
Ethiopia
East
FPG
Cross-sectional
722
11.5

Elmadhoun et al. [32]
Urban
Sudan
East
FPG
Cross-sectional
954
5.97

Ludwig et al. [16]
Urban
Tanzania
East
HbA1c
Cross-sectional
382
9

Ahmed, 2017
Rural
Egypt
North
OGTT
Cross-sectional
1255
4.2

Balde et al. [23]
Rural and urban
Guinea
West
FPG
Cross-sectional
1100
3.19

Worede et al. [20]
Rural
Ethiopia
East
FPG
Cross-sectional
392
2.3

Animaw and Seyoum [1]
Rural and urban
Ethiopia
East
FPG
Cross-sectional
1405
2.49

3.2. Heterogeneity and Publication Bias

The included articles exhibited high heterogeneity according to the test (), which is indicative of using a random effects model. In addition, to minimize the random variations between the point estimates of the primary study, subgroup analysis was done based on the residence, region, and method of diagnosis. Moreover, a univariate metaregression model was used by taking the sample size and publication year to identify the possible source of heterogeneity, but none of them was statistically significant. The high heterogeneity may be due to the significant difference in sample size, lifestyle, and genetic factors. The Begg rank correlation () and Egger weighted regression statistics () indicated that there was publication bias. Duval and Tweedie’s trim and fill analysis in the random effects model was applied to fix the publication bias.

3.3. Outcome Measures

The analysis of seventeen studies, according to the DerSimonian-Laird random effects model, revealed that the pooled prevalence of UDM among the African communities was 5.37% (95% CI: 4.31, 6.43) (Figure 2). Subgroup analyses showed that the prevalence of UDM in the urban population (8.68%, 95% CI: 5.33, 12.03) was twice higher than that in the rural population (3.93%, 95% CI: 2.91, 4.95) (Figure 3). In addition, results from subgroup analyses showed that the prevalence of UDM by the OGTT diagnostic method (8.84%, 95% CI: 1.95, 15.73) was higher than that by the FPG diagnostic method (4.54%, 95% CI: 3.59, 5.49) in the study (Figure 4).

Figure 2: Forest plot of seventeen studies that quantitatively assessed the prevalence of UDM in the African population.

Figure 3: Forest plot of studies that quantitatively assessed the prevalence of UDM in the African population by the residence.

Figure 4: Forest plot of studies that quantitatively assessed the prevalence of UDM in the African population by the diagnostic methods.

4. Discussion

The pooled prevalence of UDM among the African communities was 5.3% (95% CI: 4.31, 6.43). The finding from this pooled result indicates that the proportion of UDM cases was inconsistent with the African estimated prevalence of diabetes of 5.7% (19.8 million) in the age group of 20-79 years [33]. This may be due to poor health systems and lack of awareness in the general population. In addition, the pooled prevalence of UDM in Africa was in line with the population-based study in Qatar (5.9%) [11]. This may be because Qatar has a high national prevalence of DM that is due to genetic factors. The African pooled prevalence of UDM was lower than that of studies done in Germany (9.7%) [34], in India (7.2% and 7%) [10, 35], and in Iraq (11%) [36]. The difference might be due to the fact that these studies use OGTT for the definition of DM, while most of the studies included in our meta-analysis were done on FPG, which may underestimate the prevalence of UDM in our study.

However, the prevalence of UDM in this study was higher than that in studies done in Russia (2.9%) [13], China (4.1%) [14], Iran (2.7%) [37], and the USA (0.56%, 4.1%) [5, 38]. This could be due to limited knowledge, attitude, and practice among communities and policy makers in Africa [7, 39].

Based on the subgroup analysis, the prevalence of UDM in the urban population was 8.68% (95% CI: 5.33, 12.03), which was higher than that in studies done in the urban population of India (2.87%) [40], Qatar (5.9%) [11], Indonesia (3.5%) [41], and Iran (5.1%) [12]. The prevalence of UDM in the rural population of Africa was 3.93% (95% CI: 2.91, 4.95) which is higher than that in studies done in the rural population of India (2.87%) [40]. This may be due to lack of awareness towards diabetes diagnosis and symptoms among rural African populations.

In our study, the prevalence of UDM in the urban population was two times higher than that in the rural population, which is different from studies done in Russia that showed that UDM was higher in the rural population than in the urban population (3.8% rural and 2.7% urban) [13]. Similarly, studies have reported a two- to five-fold increase in the risk of diabetes with urban residence [42, 43]. Urbanization is also associated with decreased physical activity energy expenditure, an independent risk factor for the metabolic syndrome [44].

In this study, the prevalence of UDM by the OGTT diagnostic method was higher than that by the FPG diagnostic method. This finding was inconsistent with the recommended diagnostic methods by the American Diabetes Association, which mainly promotes the use of the OGTT for screening of new cases of diabetes [45]. This study highlights the need to develop DM awareness and screening strategies or policy to control DM burden and their complications in African population.

5. Conclusion

The results of this regional study confirm the alarmingly high proportions of UDM in many areas of the African population. UDM is harmful and costly, both financially and in terms of complications for individuals and communities and for the health systems. As most of the burden of diabetes was related to its complications, a prevention program based on family history and other targeted screening methods could be an effective way in managing diabetes in African countries.

6. Strength and Limitation

This study is the first review and meta-analysis to use a quantitative approach to pool the prevalence of undiagnosed diabetes mellitus in the general population of Africa.

The first limitation of this study was that only English research articles were considered in conducting this region-based review. In addition, all of the studies included in this review were cross-sectional in nature; as a result, the outcome variable might be affected by other confounding variables. Furthermore, in this meta-analysis, most of the studies were from the eastern and western part of Africa. Therefore, some regions may be underrepresented due to the limited number of studies included.

Abbreviations

DM: | Diabetes mellitus
UDM: | Undiagnosed diabetes mellitus
OGTT: | Oral glucose tolerance test
FPG: | Fasting blood glucose
CI: | Confidence interval
WHO: | World Health Organization.

Conflicts of Interest

The authors declare that they have no competing interests.

Authors’ Contributions

DA is responsible for the conception of the research idea. DA and YA are responsible for the study search, quality assessment, analysis, interpretation, and drafting of the manuscript. All authors read and approved the final manuscript.

Acknowledgments

The authors would like to thank the ASLM/2018 conference organizers and participants in Invisible Threat: the Non-Communicable Diseases Perspective.

References

W. Animaw and Y. Seyoum, “Increasing prevalence of diabetes mellitus in a developing country and its related factors,” PLoS One, vol. 12, no. 11, article e0187670, 2017.

C. D. Mathers and D. Loncar, “Projections of global mortality and burden of disease from 2002 to 2030,” PLoS Medicine, vol. 3, no. 11, article e442, 2006.

International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 8th edition, 2017.

J. Beagley, L. Guariguata, C. Weil, and A. A. Motala, “Global estimates of undiagnosed diabetes in adults,” Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 150–160, 2014.

L. Dwyer-Lindgren, J. P. Mackenbach, F. J. van Lenthe, A. D. Flaxman, and A. H. Mokdad, “Diagnosed and undiagnosed diabetes prevalence by county in the U.S., 1999–2012,” Diabetes Care, vol. 39, no. 9, pp. 1556–1562, 2016.

P. Zhang, X. Zhang, J. Brown et al., “Global healthcare expenditure on diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, no. 3, pp. 293–301, 2010.

W. K. Maina, Z. M. Ndegwa, E. W. Njenga, and E. W. Muchemi, “Knowledge, attitude and practices related to diabetes among community members in four provinces in Kenya: a cross-sectional study,” Pan African Medical Journal, vol. 7, no. 1, 2011.

A. Chawla, R. Chawla, and S. Jaggi, “Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum?” Indian Journal of Endocrinology and Metabolism, vol. 20, no. 4, pp. 546–551, 2016.

L. C. Plantinga, D. C. Crews, J. Coresh et al., “Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 4, pp. 673–682, 2010.

S. N. Akhtar and P. Dhillon, “Prevalence of diagnosed diabetes and associated risk factors: evidence from the large-scale surveys in India,” Journal of Social Health and Diabetes, vol. 5, no. 1, pp. 028–036, 2017.

A. Bener, M. Zirie, I. M. Janahi, A. O. A. A. al-Hamaq, M. Musallam, and N. J. Wareham, “Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar,” Diabetes Research and Clinical Practice, vol. 84, no. 1, pp. 99–106, 2009.

F. Hadaegh, M. R. Bozorgmanesh, A. Ghasemi, H. Harati, N. Saadat, and F. Azizi, “High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study,” BMC Public Health, vol. 8, no. 1, p. 176, 2008.

I. I. Dedov, M. V. Shestakova, and G. R. Galstyan, “The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study),” Diabetes Mellitus, vol. 19, no. 2, pp. 104–112, 2016.

Y. Dong, W. Gao, H. Nan et al., “Prevalence of type 2 diabetes in urban and rural Chinese populations in Qingdao, China,” Diabetic Medicine, vol. 22, no. 10, pp. 1427–1433, 2005.

M. Bos and C. Agyemang, “Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review,” BMC Public Health, vol. 13, no. 1, p. 387, 2013.

C. Ludwig, M. Streicher, S. D. Habicht, M. E. Swai, and M. B. Krawinkel, “Targeted screening reveals high numbers of prediabetes and diabetes mellitus in Moshi, Tanzania,” Journal of Diabetes & Metabolism, vol. 8, no. 1, 2017.

S. M. Abebe, Y. Berhane, A. Worku, and A. Assefa, “Diabetes mellitus in North West Ethiopia: a community based study,” BMC Public Health, vol. 14, no. 1, p. 97, 2014.

Y. G. M. Megerssa, S. Birru, A. Goshu, and D. Tesfaye, “Prevalence of undiagnosed diabetes mellitus and its risk factors in selected institutions at Bishoftu town, East Shoa, Ethiopia,” Journal of Diabetes & Metabolism, vol. S12, no. 008, pp. 2–7, 2013.

A. T. Wondemagegn, H. M. Bizuayehu, D. D. Abie, G. M. Ayalneh, T. Y. Tiruye, and M. T. Tessema, “Undiagnosed diabetes mellitus and related factors in East Gojjam (NW Ethiopia) in 2016: a community-based study,” Journal Of Public Health Research, vol. 6, no. 1, 2017.

A. Worede, S. Alemu, Y. A. Gelaw, and M. Abebe, “The prevalence of impaired fasting glucose and undiagnosed diabetes mellitus and associated risk factors among adults living in a rural Koladiba town, northwest Ethiopia,” BMC Research Notes, vol. 10, no. 1, p. 251, 2017.

W. Seifu, K. Woldemichael, and B. Tsehaineh, “Prevalence and risk factors for diabetes mellitus and impaired fasting glucose among adults aged 15-64 years in Gilgel Gibe Field Research Center, Southwest Ethiopia, 2013:through a WHO step wise approach,” MOJ Public Health, vol. 2, no. 5, 2015.

S. K. M. Noor, S. O. E. Bushara, A. A. Sulaiman, W. M. Y. Elmadhoun, and M. H. Ahmed, “164 Undiagnosed diabetes mellitus in rural communities in Sudan: prevalence and risk factors,” Eastern Mediterranean Health Journal, vol. 21, no. 3, pp. 164–170, 2015.

N. M. Balde, A. Camara, A. A. Diallo et al., “Prevalence and awareness of diabetes in Guinea: findings from a WHO STEPS,” Journal of Endocrinology, Metabolism and Diabetes of South Africa, vol. 22, no. 3, pp. 36–42, 2017.

J. B. Echouffo-Tcheugui, A. Dzudie, M. E. Epacka et al., “Prevalence and determinants of undiagnosed diabetes in an urban Sub-Saharan African population,” Primary Care Diabetes, vol. 6, no. 3, pp. 229–234, 2012.

G. Meiloud, I. Arfa, R. Kefi et al., “Type 2 diabetes in Mauritania: prevalence of the undiagnosed diabetes, influence of family history and maternal effect,” Primary Care Diabetes, vol. 7, no. 1, pp. 19–24, 2013.

S. M. Seck, D. G. Dia, D. Doupa et al., “Diabetes burden in urban and rural Senegalese populations: a cross-sectional study in 2012,” International Journal of Endocrinology, vol. 2015, Article ID 163641, 6 pages, 2015.

A. Sabir, S. Isezuo, and A. Ohwovoriole, “Dysglycaemia and its risk factors in an urban Fulani population of northern Nigeria,” West African Journal of Medicine, vol. 30, no. 5, 2011.

O. E. Enang, A. A. Otu, O. E. Essien et al., “Prevalence of dysglycemia in Calabar: a cross-sectional observational study among residents of Calabar, Nigeria,” BMJ Open Diabetes Research & Care, vol. 2, no. 1, article e000032, 2014.

R. T. Erasmus, D. J. Soita, M. S. Hassan et al., “High prevalence of diabetes mellitus and metabolic syndrome in a South African coloured population: baseline data of a study in Bellville, Cape Town,” South African Medical Journal, vol. 102, no. 11, pp. 841–844, 2012.

A. M. Zahran, A. A. Salama, and A. S. Beddah, “Undiagnosed diabetes among adult attendants of a rural primary healthcare center in Menoufia Governorate,” Menoufia Medical Journal, vol. 30, no. 3, p. 800, 2017.

K. G. M. M. Alberti, P. Z. Zimmet, and WHO Consultation, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998.

W. M. Elmadhoun, S. K. Noor, A. A. A. Ibrahim, S. O. Bushara, and M. H. Ahmed, “Prevalence of diabetes mellitus and its risk factors in urban communities of North Sudan: population-based study,” Journal of diabetes, vol. 8, no. 6, pp. 839–846, 2016.

L. Guariguata, D. R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. E. Shaw, “Global estimates of diabetes prevalence for 2013 and projections for 2035,” Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137–149, 2014.

W. Rathmann, B. Haastert, A. Icks et al., “High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000,” Diabetologia, vol. 46, no. 2, pp. 182–189, 2003.

S. R. Joshi, B. Saboo, M. Vadivale et al., “Prevalence of diagnosed and undiagnosed diabetes and hypertension in India—results from the Screening India’s Twin Epidemic (SITE) study,” Diabetes Technology & Therapeutics, vol. 14, no. 1, pp. 8–15, 2012.

A. A. Mansour, A. A. al-Maliky, B. Kasem, A. Jabar, and A. M. Khalid, “Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 7, pp. 139–144, 2014.

H. Najafipour, M. Sanjari, M. Shokoohi et al., “Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes and its predictors in general population aged 15 to 75 years: a community-based study (KERCADRS) in southeastern Iran,” Journal of Diabetes, vol. 7, no. 5, pp. 613–621, 2015.

R. T. Demmer, A. M. Zuk, M. Rosenbaum, and M. Desvarieux, “Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999–2010,” American Journal of Epidemiology, vol. 178, no. 7, pp. 1106–1113, 2013.

C. W. Kassahun and A. G. Mekonen, “Knowledge, attitude, practices and their associated factors towards diabetes mellitus among non diabetes community members of Bale Zone administrative towns, South East Ethiopia. A cross-sectional study,” PLoS One, vol. 12, no. 2, article e0170040, 2017.

P. S. Singh, H. Sharma, K. S. Zafar et al., “Prevalence of type 2 diabetes mellitus in rural population of India- a study from Western Uttar Pradesh,” International Journal of Research in Medical Sciences, vol. 5, no. 4, pp. 1363–1367, 2017.

L. Mihardja, U. Soetrisno, and S. Soegondo, “Prevalence and clinical profile of diabetes mellitus in productive aged urban Indonesians,” Journal of Diabetes Investigation, vol. 5, no. 5, pp. 507–512, 2014.

R. Chatterjee, K. M. Venkat Narayan, J. Lipscomb, and L. S. Phillips, “Screening adults for pre-diabetes and diabetes may be cost-saving,” Diabetes Care, vol. 33, no. 7, pp. 1484–1490, 2010.

N. Saquib, J. Saquib, T. Ahmed, M. A. Khanam, and M. R. Cullen, “Cardiovascular diseases and type 2 diabetes in Bangladesh: a systematic review and meta-analysis of studies between 1995 and 2010,” BMC Public Health, vol. 12, no. 1, p. 434, 2012.

F. K. Assah, U. Ekelund, S. Brage, J. C. Mbanya, and N. J. Wareham, “Urbanization, physical activity, and metabolic health in Sub-Saharan Africa,” Diabetes Care, vol. 34, no. 2, pp. 491–496, 2011.

American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 37, Supplement 1, pp. S81–S90, 2014.